Mitoxantrone Terminated Phase 3 Trials for Castration Resistant Prostate Cancer (CRPC) / Pain / Prostatic Neoplasms / Prostate Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01522443Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer